Login

Consolidated Balance Sheets (Current Period Unaudited)

In millions of USD, except per-share amounts
Q3 FY2020
As of Sep 30, 2020
Q2 FY2020
As of Jun 30, 2020
Q1 FY2020
As of Mar 31, 2020
Q4 FY2019
As of Dec 31, 2019
Q3 FY2019
As of Sep 30, 2019
Q2 FY2019
As of Jun 30, 2019
Q1 FY2019
As of Mar 31, 2019
Q4 FY2018
As of Dec 31, 2018
Q3 FY2018
As of Sep 30, 2018
Q2 FY2018
As of Jun 30, 2018
Current assets:
Cash
Accounts receivable, net
Prepaid expenses and other current assets
Total current assets
Property, plant and equipment, net
Operating lease right-of-use assets, net
Other assets
Total assets
Current liabilities:
Accounts payable
Accrued expenses
Accrued compensation
Accrued interest
Accrued stock offering expenses
Other accrued expenses
Deferred rent
Current portion of operating lease liabilities
Current portion of finance lease liabilities
Current portion of deferred revenue
Current portion of long-term debt
Total current liabilities
Long-term operating lease liabilities
Long-term finance lease liabilities
Long-term deferred rent
Long-term deferred revenue
Long-term debt
Warrant liabilities
Total liabilities
Stockholders’ equity:
Preferred stock — 10,000,000 shares authorized as of September 30, 2020 and December 31, 2019, 0 shares issued and outstanding as of September 30, 2020 and December 31, 2019
Preferred stock - Series A
Preferred stock - Series A-1
Preferred stock - Series B
Preferred stock - Series C
Preferred stock - Series C-1
Preferred stock - Series D
Total preferred stock — 10,000,000 shares authorized as of September 30, 2020 and December 31, 2019, 0 shares issued and outstanding as of September 30, 2020 and December 31, 2019
Common stock — $0.001 par value, 60,000,000 and 40,000,000 shares authorized as of September 30, 2020 and December 31, 2019, respectively, 37,752,261 and 28,231,267 shares issued and outstanding as of September 30, 2020 and December 31, 2019, respectively
Common stock - Class B- Non-voting
Common stock - Voting
Total common stock — $0.001 par value, 60,000,000 and 40,000,000 shares authorized as of September 30, 2020 and December 31, 2019, respectively, 37,752,261 and 28,231,267 shares issued and outstanding as of September 30, 2020 and December 31, 2019, respectively
Additional paid-in capital
Accumulated deficit
Preferred stock - Series A
Preferred stock - Series A-1
Preferred stock - Series B
Preferred stock - Series C
Preferred stock - Series C-1
Preferred stock - Series D
Common stock - Class B- Non-voting
Common stock - Voting
Total stockholders’ equity
Total liabilities and stockholders’ equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support